Table 5. Reversible complications due to percutaneous treatment of extra-hepatic hydatid cysts.
Reversible complications | No. of cases | % of treated non-hepatic hydatid cysts (n = 142) | % of percutaneous treatment procedures of non-hepatic cysts (n = 175) |
Allergic skin reaction (urticaria) | 1 | 0.70 | 0.57 |
“Fever & urticaria” | x * | - | - |
Pneumothorax | 1 † | 0.70 | 0.57 |
Cavity infection/abscess | 1 | 0.70 | 0.57 |
Non-classified reversible complication | 6 | 4.23 | 3.43 |
Total | 9 | 6.33 | 5.14 |
*“no complications were observed except…fever and urticaria”, no figures given (Zerem et al., 2005 [10 cases of percutaneous treated spleen hydatid cysts]).
†: Percutaneous treatment of a lung hydatid cyst (Gagal et al., 2005).